Home Open Payments Open Payments 2025 Drug and medical device makers report payments to physicians and other clinicians to CMS every year. These are general payments (meals, travel, consulting, speaking, education, gifts) for program year 2025, summarized from the public CMS file.
Total reported
$2,885,646,103
Companies that paid the most in 2025 Company Total Recipients Abbvie Inc. $197,688,945 220,460 Stryker Corporation $121,207,490 49,842 Medtronic, Inc. $107,368,366 77,693 Arthrex, Inc. $105,488,488 5,513 Boston Scientific Corporation $89,947,136 77,591 Zimmer Biomet Holdings, Inc. $78,630,580 8,062 Depuy Synthes Products, Inc. $61,501,809 272 Novo Nordisk As $57,774,123 156 Intuitive Surgical, Inc. $57,498,716 15,546 Astrazeneca Pharmaceuticals LP $52,145,553 125,520 Smith+nephew, Inc. $49,503,974 25,203 Lilly USA, LLC $48,193,471 121,502 Genzyme Corporation $42,589,619 53,172 Janssen Biotech, Inc. $41,672,789 63,069 Amgen Inc. $39,130,843 121,360 Pfizer Inc. $36,624,439 140,955 Abbott Laboratories $36,210,338 71,890 Novo Nordisk Inc $36,104,966 125,772 Globus Medical, Inc. $35,819,713 14,214 E.R. Squibb & Sons, L.L.C. $31,549,662 67,186 Alphatec Spine, Inc $28,358,605 1,171 Regeneron Healthcare Solutions, Inc. $28,332,259 49,010 Encore Medical, LP $23,997,331 594 Histosonics, Inc. $23,867,363 1,109 Align Technology, Inc. $23,775,241 24,542 Glaxosmithkline, LLC. $22,990,904 89,461 Merck Sharp & Dohme LLC $21,586,640 85,636 Ucb, Inc. $21,544,198 29,185 Galderma Laboratories, L.P. $21,406,367 22,052 Axsome Therapeutics, Inc. $20,713,266 46,108 Gilead Sciences, Inc. $20,478,812 31,827 Livanova USA, Inc. $20,376,607 2,890 Neurocrine Biosciences, Inc. $19,449,823 30,427 Novartis Pharmaceuticals Corporation $19,181,738 82,836 Takeda Pharmaceuticals U.S.A., Inc. $18,810,585 51,665 Csl Plasma Inc. $17,375,911 269 Alcon Vision LLC $16,950,772 31,506 Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) $16,783,544 46,200 Medical Device Business Services, Inc. $15,883,640 6,409 Edwards Lifesciences Corporation $15,775,618 17,597 Madrigal Pharmaceuticals $15,390,350 19,230 Bausch & Lomb Americas Inc. $15,027,873 24,798 Teva Pharmaceuticals USA, Inc. $14,918,421 32,891 Boehringer Ingelheim Pharmaceuticals, Inc. $14,649,061 67,305 Otsuka America Pharmaceutical, Inc. $13,706,249 56,585 Incyte Corporation $13,150,484 22,668 Bayer Healthcare Pharmaceuticals Inc. $12,633,242 68,412 Treace Medical Concepts, Inc. $11,965,540 4,528 Alkermes, Inc. $11,693,904 24,361 Angiodynamics, Inc. $10,890,704 5,265
Source: CMS Open Payments general payment data, program year 2025. Research payments and ownership interests are not included. Receiving payments does not imply wrongdoing. Original records: openpaymentsdata.cms.gov .